These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7272595)
21. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs. Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart. Takahashi K; Taira N Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072 [TBL] [Abstract][Full Text] [Related]
23. Calcium channel blocker nisoldipine limits ischemic damage in rat kidney. Hertle L; Garthoff B J Urol; 1985 Dec; 134(6):1251-4. PubMed ID: 4057426 [TBL] [Abstract][Full Text] [Related]
24. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion. Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252 [TBL] [Abstract][Full Text] [Related]
25. Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers. Kass RS J Pharmacol Exp Ther; 1982 Nov; 223(2):446-56. PubMed ID: 7150411 [TBL] [Abstract][Full Text] [Related]
26. Effect of nifedipine and niludipine on myocardial pH in the ischemic canine heart. Ichihara K; Sakai K; Abiko Y Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):58-73. PubMed ID: 3718082 [TBL] [Abstract][Full Text] [Related]
27. Timely administration of nisoldipine essential for prevention of myocardial ATP catabolism. De Jong JW Eur J Pharmacol; 1985 Nov; 118(1-2):53-9. PubMed ID: 4085550 [TBL] [Abstract][Full Text] [Related]
28. The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats. Fagbemi O; Kane KA; McDonald FM; Parratt JR; Rothaul AL Br J Pharmacol; 1984 Sep; 83(1):299-304. PubMed ID: 6487894 [TBL] [Abstract][Full Text] [Related]
29. Reduced glycolysis by nisoldipine treatment of ischemic heart. de Jong JW; Huizer T J Cardiovasc Pharmacol; 1985; 7(3):497-500. PubMed ID: 2410680 [TBL] [Abstract][Full Text] [Related]
30. Acute coronary hemodynamic effects of equihypotensive doses of nisoldipine and diltiazem. Suryapranata H; Serruys PW; Soward AL; Planellas J; Vanhaleweyk G; Hugenholtz PG Aust N Z J Med; 1985 Dec; 15(6):685-90. PubMed ID: 3869435 [TBL] [Abstract][Full Text] [Related]
31. [Effect of the calcium antagonist nisoldipine on electrophysiologic parameters in the human]. Klein HH; Nordbeck H; Kreuzer H Z Kardiol; 1983 Mar; 72(3):180-2. PubMed ID: 6858297 [TBL] [Abstract][Full Text] [Related]
32. The effect of a calcium channel antagonist, Nisoldipine, on the ischemia-induced change of canine sarcolemmal membrane. Takahashi K; Kako KJ Basic Res Cardiol; 1983; 78(3):326-37. PubMed ID: 6311155 [TBL] [Abstract][Full Text] [Related]
33. Comparative coronary vasodilatory effects of nifedipine and niludipine. Ogawa K; Wakamasu Y; Ito T; Suzuki T; Yamazaki N Arzneimittelforschung; 1981; 31(5):770-3. PubMed ID: 7196733 [TBL] [Abstract][Full Text] [Related]
34. Effects of niludipine on regional myocardial blood flow and regional myocardial function in the dog with partial occlusion of the coronary artery. Nomura H; Nagata K; Futamura Y; Mochizuki K; Hama Y; Sotobata I; Yasui S Arzneimittelforschung; 1980; 30(8):1258-62. PubMed ID: 7192140 [TBL] [Abstract][Full Text] [Related]
35. Nisoldipine and perfusion of post-stenotic myocardium in conscious pigs with different degrees of concentric stenosis. Duncker DJ; Heiligers JP; Saxena PR; Verdouw PD Br J Pharmacol; 1988 May; 94(1):219-27. PubMed ID: 3401639 [TBL] [Abstract][Full Text] [Related]
36. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects. Pasanisi F; Meredith PA; Reid JL Eur J Clin Pharmacol; 1985; 29(1):21-4. PubMed ID: 4054203 [TBL] [Abstract][Full Text] [Related]
37. Effects of nisoldipine on left ventricular function during exercise or cold pressor stress. Dymond DS; Caplin JL; O'Keefe JC; Banim S Eur Heart J; 1987 Nov; 8 Suppl K():27-33. PubMed ID: 3450520 [TBL] [Abstract][Full Text] [Related]
38. Effect of nisoldipine on the oxymyoglobin level of myocardial cells in hypoxic, perfused rat hearts. Hara A; Matsumura H; Abiko Y Arch Int Pharmacodyn Ther; 1989; 298():78-89. PubMed ID: 2757469 [TBL] [Abstract][Full Text] [Related]
39. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Friedel HA; Sorkin EM Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058 [TBL] [Abstract][Full Text] [Related]